Status:
COMPLETED
Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease
Lead Sponsor:
Heart Force Medical Inc.
Conditions:
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate a new, non-invasive method for detecting coronary artery disease (CAD) using seismocardiography (SCG) and gyrocardiography (GCG). These techniques measure small vibrations ...
Eligibility Criteria
Inclusion
- Aged 18 years or older.
- Suspected CAD, based on clinical evaluation.
- Able to provide informed consent.
Exclusion
- Pregnant or breastfeeding women.
- Presence of implanted cardiac devices (e.g., pacemakers, implantable cardioverter defibrillators) that may interfere with SCG/GCG signal acquisition.
- Severe arrhythmias that may affect signal interpretation.
- Inability to maintain required testing positions (supine and sitting).
- Medical conditions preventing informed consent (e.g., severe cognitive impairment).
Key Trial Info
Start Date :
May 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2021
Estimated Enrollment :
1534 Patients enrolled
Trial Details
Trial ID
NCT06880120
Start Date
May 19 2021
End Date
November 28 2021
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Republic Specialized Scientific-Practical Medical Center of Cardiology (RSPCMCC)
Tashkent, Uzbekistan